Investors / Debiopharm Innovation Fund
Debiopharm Innovation Fund
Debiopharm Innovation Fund is a corporate investor based in Switzerland. Debiopharm Innovation Fund has backed 1 Canadian AI company in the Index, joining 1 tracked round and leading 1. The most recent was Altis Labs's US$6M seed round in June 2023.
Corporate based in Switzerland. 1 Canadian AI company in the Index, 1 tracked round, 1 as lead.
- Type
- Corporate
- HQ country
- Switzerland
- Companies
- 1
- Tracked rounds
- 1
- Led
- 1
- First tracked deal
- Altis Labs, Jun 2023
- Latest tracked deal
- Altis Labs, Jun 2023
Portfolio
| Company | Rounds joined (date, round size) | Company's total raised | Role |
|---|---|---|---|
| Altis Labs | Seed · Jun 2023 · US$6M round (lead) | US$31M | Lead |
A round's size is the whole round as announced, not this investor's cheque.
Frequent co-investors
Benchstrength (1 shared round)
Data as of November 10, 2026.